News this week (1st May) that Gilead has inked a partnership with Alphabet subsidiary Verily is proof of the growing appetite tech and life science companies for working together.
But, for all the lofty ambitions expressed in the business news pages, these companies are fundamentally different in many ways – not least in how they communicate. I don’t think I’ll ever see a life sciences CEO describe a new market as a “major strategic thrust” as Tim Cook did on Apple’s earnings call this week. Ironically, he was referring to the health sector.
It’s a dynamic that fascinates us here at Ruder Finn. Working with leading businesses in both of these sectors, we are often called upon to help clients accelerate their digital health strategies, through external communications and internal culture change.
We’re inviting companies in medtech and digital health of all sizes to tell us, confidentially, about their experiences working with life sciences firms. In partnership with IMT Innovation we’re running a brief survey. It’ll take about five minutes to complete. If you’d like to see the findings, just let us know and we’d be happy to share them with you when they’re done.